SSG
ABMD

Summit Securities Group’s Abiomed Inc ABMD Stock Holding History

Summit Securities Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66
Closed -$16K – 1480
2022
Q3 		$16K Sell
66
-30
-31% -$8.1K ﹤0.01% 757
2022
Q2 		$24K Buy
96
+77
+405% +$20.8K ﹤0.01% 736
2022
Q1 		$6K Buy
+19
New +$5.85K ﹤0.01% 953
2015
Q3 		– Sell
-100
Closed -$7K – 551
2015
Q2 		$7K Buy
+100
New +$6.64K ﹤0.01% 395

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Summit Securities Group's ABMD Position: Q4 2022 in Review

Summit Securities Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 66 shares — an estimated $16K sold.

Summit Securities Group first reported a position in ABMD in Q2 2015 and held it in 4 quarters. The position peaked at $24K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Summit Securities Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Summit Securities Group sold 66 Abiomed Inc shares in Q4 2022, an estimated $16K.
  • Summit Securities Group first reported a position in Abiomed Inc in Q2 2015 and held it in 4 quarters.
  • Summit Securities Group's Abiomed Inc position peaked at $24K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Summit Securities Group's 13F filing for Q4 2022, filed 13 Feb 2023.